The day is marked every year to encourage awareness about how viral hepatitis can cause severe liver disease and cancer, and ...

Trontinemab’s Phase Ib/IIa Brainshuttle™ AD study continues to show rapid and robust clearance of amyloid plaques, with 91% ...